As of January 22, 2025, Health Catalyst (HCAT) has a market cap of $0.34 billion USD. According to our data, Health Catalyst is ranked No.6542 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.34 B |
-20.79%
|
Dec 31, 2024 | $0.43 B |
-23.65%
|
Dec 29, 2023 | $0.56 B |
-12.89%
|
Dec 30, 2022 | $0.65 B |
-73.17%
|
Dec 31, 2021 | $2.41 B |
-8.98%
|
Dec 31, 2020 | $2.65 B |
25.45%
|
Dec 31, 2019 | $2.11 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Allscripts
MDRX
|
$0.97 B |
0.000 M
|
USA
|
McKesson
MCK
|
$74.51 B |
-0.001 M
|
USA
|
Teladoc Health
TDOC
|
$1.72 B |
83.501 M
|
USA
|
Veeva Systems
VEEV
|
$36.94 B |
-0.001 M
|
USA
|
Omnicell
OMCL
|
$1.97 B |
-0.016 B
|
USA
|
Evolent Health
EVH
|
$1.13 B |
0.000 M
|
USA
|
Market Cap | = | HCAT Stock Price | * | HCAT Shares Outstanding |
= | $5.60 | * | 60.85 M | |
= | $0.34 B |